Literature DB >> 19515604

Expression of cell cycle regulator cdk2ap1 suppresses tumor cell phenotype by non-cell-autonomous mechanisms.

Olga Zolochevska1, Marxa L Figueiredo.   

Abstract

We evaluated the effect of expressing the cell cycle regulator cdk2ap1 in epithelial or stromal cell compartments to reduce SCC growth in vitro and in vivo. Cell-autonomous and/or non-cell-autonomous expression of cdk2ap1 reduced tumor growth and invasion and altered cell cycle, adhesion, invasion, angiogenesis, and apoptotic gene expression, as assessed by several in vitro phenotype assays, quantitative real-time PCR, and in vivo molecular imaging using a novel three-way xenograft animal model. Our findings suggest that the interactions between cancer cells and fibroblasts that promote abnormal growth can be minimized by expressing cdk2ap1, supporting a novel concept by which tumor/growth suppressor genes can impact tumorigenesis phenotypes from non-cell-autonomous interactions within the tumor microenvironment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19515604      PMCID: PMC2735612          DOI: 10.1016/j.oraloncology.2009.05.001

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  25 in total

Review 1.  Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion.

Authors:  M Martin; P Pujuguet; F Martin
Journal:  Pathol Res Pract       Date:  1996-07       Impact factor: 3.250

2.  A transient three-plasmid expression system for the production of high titer retroviral vectors.

Authors:  Y Soneoka; P M Cannon; E E Ramsdale; J C Griffiths; G Romano; S M Kingsman; A J Kingsman
Journal:  Nucleic Acids Res       Date:  1995-02-25       Impact factor: 16.971

3.  A functional polymorphism in the matrix metalloproteinase-1 gene promoter is associated with susceptibility and aggressiveness of head and neck cancer.

Authors:  Pornchai O-charoenrat; Piyavadee Leksrisakul; Supatra Sangruchi
Journal:  Int J Cancer       Date:  2006-05-15       Impact factor: 7.396

4.  p12CDK2-AP1 gene therapy strategy inhibits tumor growth in an in vivo mouse model of head and neck cancer.

Authors:  Marxa L Figueiredo; Yong Kim; Maie A R St John; David T W Wong
Journal:  Clin Cancer Res       Date:  2005-05-15       Impact factor: 12.531

Review 5.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

Authors:  H F Dvorak
Journal:  N Engl J Med       Date:  1986-12-25       Impact factor: 91.245

6.  Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene.

Authors:  R Todd; J McBride; T Tsuji; R B Donoff; M Nagai; M Y Chou; T Chiang; D T Wong
Journal:  FASEB J       Date:  1995-10       Impact factor: 5.191

7.  A third-generation lentivirus vector with a conditional packaging system.

Authors:  T Dull; R Zufferey; M Kelly; R J Mandel; M Nguyen; D Trono; L Naldini
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

8.  Calcium regulation of antigen expression on normal and malignant human squamous cells in vitro.

Authors:  H T Hoffman; M Subnani; M Cha; L Kidd; J Landman; R Tooley; T E Carey
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1990-03

9.  Malignant transformation of NIH-3T3 cells after subcutaneous co-injection with a reconstituted basement membrane (matrigel).

Authors:  R Fridman; T M Sweeney; M Zain; G R Martin; H K Kleinman
Journal:  Int J Cancer       Date:  1992-07-09       Impact factor: 7.396

10.  Identification of angiogenesis/metastases genes predicting chemoradiotherapy response in patients with laryngopharyngeal carcinoma.

Authors:  Ian Ganly; Simon Talbot; Diane Carlson; Agnes Viale; Ellie Maghami; Iman Osman; Eric Sherman; David Pfister; Shaokun Chuai; Ashok R Shaha; Dennis Kraus; Jatin P Shah; Nicholas D Socci; Bhuvanesh Singh
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

View more
  6 in total

1.  Interleukin-27 gene delivery for modifying malignant interactions between prostate tumor and bone.

Authors:  Olga Zolochevska; Jayne Ellis; Sangram Parelkar; Delphine Chan-Seng; Todd Emrick; Jingna Wei; Igor Patrikeev; Massoud Motamedi; Marxa L Figueiredo
Journal:  Hum Gene Ther       Date:  2013-11-06       Impact factor: 5.695

2.  Progesterone is primary regulator of Cdk2ap1 gene expression and tissue-specific expression in the uterus.

Authors:  Y P Cheon; C H Kim
Journal:  J Endocrinol Invest       Date:  2010-03-30       Impact factor: 4.256

Review 3.  Double edge: CDK2AP1 in cell-cycle regulation and epigenetic regulation.

Authors:  D T W Wong; J J Kim; O Khalid; H H Sun; Y Kim
Journal:  J Dent Res       Date:  2011-08-24       Impact factor: 6.116

4.  Cyclin-dependent kinase inhibitor 3 (CDKN3) novel cell cycle computational network between human non-malignancy associated hepatitis/cirrhosis and hepatocellular carcinoma (HCC) transformation.

Authors:  L Wang; L Sun; J Huang; M Jiang
Journal:  Cell Prolif       Date:  2011-06       Impact factor: 6.831

5.  Ligand-Mediated Targeting of Cytokine Interleukin-27 Enhances Its Bioactivity In Vivo.

Authors:  Marxa L Figueiredo; Manoel Figueiredo Neto; Janelle Wes Salameh; Richard E Decker; Rachel Letteri; Delphine Chan-Seng; Todd Emrick
Journal:  Mol Ther Methods Clin Dev       Date:  2020-03-30       Impact factor: 6.698

6.  Sonodelivery Facilitates Sustained Luciferase Expression from an Episomal Vector in Skeletal Muscle.

Authors:  Manoel Figueiredo Neto; Rachel Letteri; Delphine Chan-Seng; Todd Emrick; Marxa L Figueiredo
Journal:  Materials (Basel)       Date:  2015-07-22       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.